By comparison, antibody treatments administered intravenously cost about$ 2, 000, and Merck’s experimental antiviral pill for COVID-19, called molnupiravir, is about$ 700 per course....
Earlier published results found that the antimalarial drug hydroxychloroquine and the antiparasitic ivermectin — both of which have been touted as “ miracle ” treatments for COVID-19 — were ineffective....
The researchers shared their results with the U.S. National Institutes of Health, which publishes COVID-19
综合
洛杉矶时报-世界与民族
2021-10-27 00:00:00.0